CFDE Data Portal | Search RNF139-DT

	Label	Description
	RNF139-DT Gene (Entity type)	ENSG00000245149 - RNF139 divergent transcript
	GSE168745 H-7 JHH-7 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE226249 5 V 4 PIRFENIDONE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE129542 BAT1 knockdown RNA Small Interfering 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE193993 SSTR2 knockout 5 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE216540 fulvestrant 10 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 4 v 14 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE212312 FBXW7 knockout Reh 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 7 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE190384 GSE190386 fulvestrant 1 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS

RNF139-DT

ENSG00000245149 - RNF139 divergent transcript

GSE168745 H-7 JHH-7 0 v 1 human dn

A Gene Set from LINCS

GSE226249 5 V 4 PIRFENIDONE HUMAN DN

A Gene Set from LINCS

GSE129542 BAT1 knockdown RNA Small Interfering 0 v 2 human up

A Gene Set from LINCS

GSE193993 SSTR2 knockout 5 v 3 human dn

A Gene Set from LINCS

GSE216540 fulvestrant 10 v 6 human up

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 4 v 14 human up

A Gene Set from LINCS

GSE212312 FBXW7 knockout Reh 1 v 3 human up

A Gene Set from LINCS

GSE239844 crizotinib 7 v 0 human up

A Gene Set from LINCS

GSE190384 GSE190386 fulvestrant 1 v 8 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.